BSBR
Banco Santander (Brasil) S.A.
BSBR offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has the edge over BSBR overall, supported by lower modeled downside and stronger modeled upside.
BSBR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BSBR's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BSBR.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BSBR PE Valuation
BSBR has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
BSBR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect BSBR's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over BSBR on the outlook, with more favorable earnings and revenue expectations.
BSBR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | $0.51 | +70% |
| Q2 2025 | $0.12 | -56% |
| Q1 2025 | $0.16 | -30% |
| Q4 2024 | $0.16 | -30% |
| Q3 2024 | $0.30 | +20% |
| Q2 2024 | $0.27 | +3.8% |
| Q1 2024 | $0.23 | -28% |
| Q4 2023 | $0.23 | -32% |
BSBR has the stronger earnings trend. Trailing diluted EPS is up 70% for BSBR versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
BSBR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7B | +13% |
| Q1 2026 | $6.9B | +6.7% |
| Q4 2025 | $7.6B | +20% |
| Q3 2025 | $42.9B | +611% |
| Q2 2025 | $6.2B | +18% |
| Q1 2025 | $6.4B | +17% |
| Q4 2024 | $6.3B | +11% |
| Q3 2024 | $6B | +9.4% |
BSBR has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.7% | -2.1 points |
| Q1 2026 | 12% | +6.5 points |
| Q4 2025 | 12% | -1 points |
| Q3 2025 | 11% | -5.2 points |
| Q2 2025 | 5.7% | -12 points |
| Q1 2025 | 13% | -1.5 points |
| Q4 2024 | 12% | +3.4 points |
| Q3 2024 | 16% | +4.6 points |
BSBR's operating margin was 8.7% last quarter, up 3 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over BSBR on profitability, with a higher operating margin.
BSBR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.9B | +$5B |
| Q1 2026 | $7B | +21% |
| Q4 2025 | -$3.8B | +$3.9B |
| Q3 2025 | $444.5M | -91% |
| Q2 2025 | -$2.1B | -190% |
| Q1 2025 | $5.8B | +$9.7B |
| Q4 2024 | -$7.7B | -$5.3B |
| Q3 2024 | $5B | -53% |
BSBR has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BSBR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -2.2M shares |
| 1 year | +0.2% | +16.6M shares |
| 3 years | +0.6% | +43.1M shares |
| 5 years | 0% | -2.8M shares |
| Available history | 0% | -2.8M shares |
BSBR has 7.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BSBR hasn't bought back shares in the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BSBR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BSBR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 24.0x | High |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -3.6x | Net Cash |
| Q4 2024 | -3.2x | Net Cash |
| Q3 2024 | 1.4x | Healthy |
| Q2 2024 | 3.1x | Elevated |
| Q1 2024 | 4.1x | High |
| Q4 2023 | -4.0x | Net Cash |
BSBR's net debt is more than 20 years of its operating earnings (EBITDA), up from 1.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BSBR.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BSBR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 18.6 | Oversold |
BSBR's weekly RSI is 43 (neutral) and its Stochastic is 19 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BSBR PE vs Financial Services Sector
BSBR has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BSBR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.27 | 4.7% below |
| 20 week MA | $5.49 | 8.6% below |
| 50 week MA | $5.79 | 13% below |
| 100 week MA | $5.40 | 7% below |
| 200 week MA | $5.46 | 8.1% below |
BSBR is in a downtrend: it's below all five of its weekly moving averages, and 8.1% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over BSBR on trend strength, trading above more of its moving averages.
BSBR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.4 | $8.29 | -27% |
| 2021 | $8.29 | $5.36 | -35% |
| 2022 | $5.36 | $5.47 | +2.1% |
| 2023 | $5.47 | $6.55 | +20% |
| 2024 | $6.55 | $3.87 | -41% |
| 2025 | $3.87 | $6.16 | +59% |
| 2026 YTD | $6.16 | $5.02 | -19% |
BSBR has finished lower in three of the last six years. It's down 19% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over BSBR on returns for 2026, with the stronger performance.